Clinical Trial Update: A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

View source ↗

Summary

This clinical trial update describes a study comparing the risk of serious infections and malignancies between deucravacitinib and biologics in Japanese patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Biologics (biologics)
• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Status: ACTIVE_NOT_RECRUITING